Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Midatech Pharma US Inc. | ex32_1.htm |
| EX-21.1 - EXHIBIT 21.1 - Midatech Pharma US Inc. | ex21_1.htm |
| EX-31.1 - EXHIBIT 31.1 - Midatech Pharma US Inc. | ex31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Midatech Pharma US Inc. | ex31_2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Midatech Pharma US Inc. | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - Midatech Pharma US Inc. | R9999.htm |
| 10-K - FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 - Midatech Pharma US Inc. | s22615110k.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement (No. 333-193733, No. 333-150129 and 333-187602) on Form S-8, Registration Statements (No. 333-194333, 333-173098, 333-186557 and 333-192595) on Form S-3 and Registration Statements (No. 333-165884, 333-171449, 333-179637 and 333-193054) on Form S-1 of DARA BioSciences, Inc. of our report dated March 3, 2015 relating to our audit of the consolidated financial statements, which appears in this Annual Report on Form 10-K of DARA BioSciences, Inc. for the year ended December 31, 2014.
/s/ HORNE LLP
Ridgeland, Mississippi
March 3, 2015